Sigma-Aldrich CRISPR Intellectual Property

Sigma-Aldrich Co. LLC’s CRISPR products and methods of making and using the same, as well as CRISPR services provided by MilliporeSigma, the Life Science business of Merck KGaA, are protected by one or more of the following issued patents and pending patent applications:

Patent applications and issued patents that entered their respective National Stage from PCT International Pub. No. WO 2014/089290, including, but not limited to, the following, and substitutions, divisions, continuations, reissues, reexaminations, and extensions thereof.

Australian Patent Application No. AU 2017204031; Australian Patent No. AU 2013355214; Brazil Patent Application No. 112015012375-9; Canadian Patent Application No. 2,977,152; Canadian Patent No. 2,891,347; Chinese Patent Application No. 201810540449.5; Chinese Patent Application No. 201380072477.4; European Patent Specification EP 3 138 910 B1; European Patent Application EP 3 138 911 A1; European Patent Application EP 3 138 912 A1; Israel Patent Application No. IL257178; Israel Patent No. IL238856; India Patent Application No. 1500KOLNP/2015; Japanese Patent Application No. 2015-545838; Japanese Patent Application No. 2017-115672; South Korea Patent No. 10-2015-7013843; South Korea Patent Application No. 10-2018-7001934; Singapore Patent Application No. 10201800585V; Singapore Patent No. 11201503824S; and U.S. Patent Application Serial Nos. 15/188,911; 15/188,924; 15/188,927; 15/188,931; and 15/456,204.

This website page is provided to satisfy the virtual patent marking provisions of the America Invents Act and is intended to serve as notice under 35 U.S.C. § 287(a). This page is accessible to the public without charge and associates the patented article with the number of the patent(s). 

The following list of Sigma-Aldrich products and services may not be all inclusive, and there may be one or more other patents or published patent applications covering such products or aspects of such products. In addition, other Sigma-Aldrich products and services not listed here may be protected by one or more patents and patent applications.

  1. CRISPR reagents
  2. Donor oligos or plasmids
  3. Validation Services
  4. Cell Line Models and Engineering Service